SCHEMBL6777161

SCHEMBL6777161

CC(Cl)COC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6420400 0.81 ALDH1A1 (0.41)
SCHEMBL1745 0.81
Ammonia Solution, Strong SCHEMBL28186859 0.79
SCHEMBL203347 0.79
SCHEMBL9581609 0.79
Hydrochloric Acid SCHEMBL28817307 0.79
SCHEMBL6420402 0.79
SCHEMBL1923101 0.78
SCHEMBL23221980 0.77 TSHR (0.32)
SCHEMBL16447031 0.77 TSHR (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373633-B1 METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES BOREALIS AGROLINZ MELAMINE (AT) 2014-04-16 EP claimed
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates BOREALIS AGROLINZ MELAMINE GMBH (AT) 2011-12-01 US claimed
EP-3793988-B1 SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING CTXT PTY LTD (AU) 2023-11-15 EP disclosed
US-20110295001-A1 Method for Producing Triazine Carbamates Using Chloroformates BOREALIS AGROLINZ MELAMINE GMBH (AT) 2011-12-01 US disclosed
US-6765015-B2 ANTICARCINOGENIC/ANTITUMOR AGENTS SUCH AS N-(2?-BROMO-3? METHYL)-BUTANOYL-N-DEBENZOYL-CEPHALOMANNINE XECHEM INTERNATIONAL, INC. 2004-07-20 US disclosed
EP-1105118-A4 HALOGENATED PACLITAXEL DERIVATIVES XECHEM INC (US) 2003-02-26 EP disclosed
US-20020107409-A1 Halogenated paclitaxel derivatives XECHEM, INC. 2002-08-08 US disclosed
EP-1105118-A1 HALOGENATED PACLITAXEL DERIVATIVES Xechem, Inc. (US) 2001-06-13 EP disclosed
US-6124313-A ACTIVE DRUG FOR TREATING GASTRO-INTESTINAL AILMENTS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-09-26 US disclosed
WO-1999025334-A1 HALOGENATED PACLITAXEL DERIVATIVES XECHEM INTERNATIONAL, INC. (US) 1999-05-27 WO disclosed
US-4313838-A Preparation and use of xanthogen chloropropyl formate flotation reagents ESSEX CHEMICAL CORPORATION 1982-02-02 US disclosed
US-4191641-A COPPER SULFIDE ORES Mineric Corporation (US) 1980-03-04 US disclosed